Annual report [Section 13 and 15(d), not S-K Item 405]

NON CONTROLLING INTEREST (Details)

v3.26.1
NON CONTROLLING INTEREST (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Net loss $ (3,037,545) $ (3,508,763) $ (5,212,102)
Net loss attributable to the non-controlling interest   (68,617) (105,978)
BioCorRx Pharmaceuticals, Inc [Member]      
Net loss   $ (283,521) $ (435,421)
Average Non-controlling interest percentage of profit/losses   24.20% 24.20%
Net loss attributable to the non-controlling interest   $ (68,612) $ (105,372)
Joseph DeSanto MD [Member]      
Net loss   $ (15) $ (1,731)
Average Non-controlling interest percentage of profit/losses   35.00% 35.00%
Net loss attributable to the non-controlling interest   $ (5) $ (606)